Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING
Schiller
Ampronix

Noncompliant Coronary Balloon Helps Navigate Tortuous Anatomy

By HospiMedica International staff writers
Posted on 16 Jun 2014
Image: The NC Euphora noncompliant balloon dilatation catheter with tapered tip (Photo courtesy Medtronic).
Image: The NC Euphora noncompliant balloon dilatation catheter with tapered tip (Photo courtesy Medtronic).
A new noncompliant coronary balloon provides superior deliverability and controlled growth in challenging angioplasty procedures.

The NC Euphora Noncompliant Balloon Dilatation Catheter offers enhanced deliverability through tight lesions via proprietary PowerTrac technology, thus requiring less force application to provide tracking through tortuous anatomy. An optimized tapered tip design and low lesion entry profile improve flexibility and allow for reliable stent re-cross when traversing long, challenging lesions, so that the balloon does not catch on a strut when passing through a deployed stent.

The balloon is made of strong, durable, and flexible Low Inflation Growth, High Track (LIGHT) material that provides high pressure capability, enabling the NC Euphora to expand consistently within the stent area at a rated burst pressure—the maximum pressure that the balloon can be repeatedly inflated in a safe manner—of up to 20 atmospheres without bursting. Significantly low radial growth reduces unwanted vessel expansion and longitudinal growth beyond the stent length, minimizing damage to the surrounding healthy artery. The NC Euphora Noncompliant Balloon Dilatation Catheter is a product of Medtronic (Minneapolis, MN, USA).

“NC Euphora expands our interventional portfolio with another clinically-relevant tool that was developed with both interventionalists and cath lab teams' needs in mind,” said Jason Weidman, vice president and general manager of Medtronic's coronary business. “With the addition of a premium noncompliant balloon, our interventional customers have a complement to the other innovative Medtronic offerings throughout the entire procedure for their most difficult and challenging cases.”

“When using a noncompliant balloon, deliverability and re-cross are important characteristics, especially when faced with challenging coronary anatomy,” said consultant interventional cardiologist Robert Gerber, MD, PhD, of Eastbourne District General Hospital East Sussex Healthcare NHS Trust, and preclinical researcher for the NC Euphora balloon. “The NC Euphora balloon was designed to meet these demands and provide reliable performance with no tradeoffs in the moment that we need it most.”

Related Links:

Medtronic
Eastbourne District General Hospital East Sussex Healthcare NHS Trust



Centurion Service
Bovie Medical
MinXray

Channels

Critical Care

view channel
Image: The Trellis peripheral infusion system (Photo courtesy of Covidien).

Thrombolytic Drug Delivery Device Dissolves Blood Clots

A redesigned peripheral infusion system enables focused treatment of blood clots to avoid potential post-thrombotic syndrome (PTS). The updated Trellis peripheral infusion system is a pharmacomechanical... Read more

Women's Health

view channel
Image: A prototype contraceptive implant (Photo courtesy of MicroCHIPS).

Contraceptive Implant Hails New Era of Birth Control

A fingernail-sized implant holds enough 30-microgram daily doses of levonorgestrel to provide contraception for 16 years. Developed by MicroCHIPS (Lexington, MA, USA), a MIT (Cambridge, MA, USA) startup,... Read more

Health IT

view channel
Image: The Health eResearch Center UV2 supercomputer (Photo courtesy of HeRC).

Supercomputer Accelerates Pace of Health Research

The University of Manchester (United Kingdom) is financing a new supercomputer system that can analyze bigger and more complex sets of information. The Health eResearch Center (HeRC; Manchester, United... Read more

Business

view channel

Spectranetics Completes Acquisition of AngioScore

Spectranetics (Colorado Springs, CO, USA) has completed the acquisition of AngioScore (Fremont, CA, USA), a leading developer, manufacturer, and marketer of cardiovascular specialty balloons. The transaction, for USD 230 million in cash and contingent commercial and regulatory milestone payments, will combine differentiated,... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.